Introduction: The type 2 cannabinoid (CB2) receptor is part of the endocannabinoid system and has been Suggested as a mediator of several central and peripheral inflammatory processes. Imaging of the CB2 receptor has been unsuccessful so far. We synthesized and evaluated a carbon-11- and a fluorine-18-labeled 2-oxoquinoline derivative as new PET tracers with high specificity and affinity for the CB2 receptor.status: publishe
As part of our efforts to develop CB2 PET imaging agents, we investigated 2,5,6-substituted pyridine...
The cannabinoid type 2 (CB2) receptor has emerged as a valuable target for therapy and imaging of im...
The cannabinoid receptor type 2 (CB2) has a very low expression level in brain tissue under basal co...
Introduction: The type 2 cannabinoid (CB2) receptor is part of the endocannabinoid system and has be...
Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and th...
Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and th...
Introduction: The cannabinoid type 2 receptor (CB2 receptor) is part of the endocannabinoid system a...
The cannabinoid receptor type 2 (CB2) is part of the endocannabinoid system and has gained growing a...
The type 2 cannabinoid receptor (CB(2)R) is part of the endocannabinoid system and is expressed in t...
Despite the broad implications of the cannabinoid type 2 receptor (CB2) in neuroinflammatory process...
In the present work, we report the synthesis of new aryliodonium salts used as precursors of single-...
The type 2 cannabinoid receptor (CB2) is a member of the endocannabinoid system and is known for its...
The type 2 cannabinoid receptor (CB₂R) is part of the endocannabinoid system and is expressed in tis...
Abstract Upregulation of the cannabinoid type 2 receptors (CB2R) unveils inflammation processes of ...
The cannabinoid receptor type 2 (CB2) has a very low expression level in brain tissue under basal co...
As part of our efforts to develop CB2 PET imaging agents, we investigated 2,5,6-substituted pyridine...
The cannabinoid type 2 (CB2) receptor has emerged as a valuable target for therapy and imaging of im...
The cannabinoid receptor type 2 (CB2) has a very low expression level in brain tissue under basal co...
Introduction: The type 2 cannabinoid (CB2) receptor is part of the endocannabinoid system and has be...
Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and th...
Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and th...
Introduction: The cannabinoid type 2 receptor (CB2 receptor) is part of the endocannabinoid system a...
The cannabinoid receptor type 2 (CB2) is part of the endocannabinoid system and has gained growing a...
The type 2 cannabinoid receptor (CB(2)R) is part of the endocannabinoid system and is expressed in t...
Despite the broad implications of the cannabinoid type 2 receptor (CB2) in neuroinflammatory process...
In the present work, we report the synthesis of new aryliodonium salts used as precursors of single-...
The type 2 cannabinoid receptor (CB2) is a member of the endocannabinoid system and is known for its...
The type 2 cannabinoid receptor (CB₂R) is part of the endocannabinoid system and is expressed in tis...
Abstract Upregulation of the cannabinoid type 2 receptors (CB2R) unveils inflammation processes of ...
The cannabinoid receptor type 2 (CB2) has a very low expression level in brain tissue under basal co...
As part of our efforts to develop CB2 PET imaging agents, we investigated 2,5,6-substituted pyridine...
The cannabinoid type 2 (CB2) receptor has emerged as a valuable target for therapy and imaging of im...
The cannabinoid receptor type 2 (CB2) has a very low expression level in brain tissue under basal co...